Fragmentomic analysis of circulating tumor DNA-targeted cancer panelsKyle T. Helzer, Shuang G. Zhao, Marina N. Sharifi et al.|Annals of Oncology|2023Cited by 70
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancerShuang G. Zhao, Joshua M. Lang, Nan Sethakorn et al.|Journal of Clinical Investigation|2022Cited by 33
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell CarcinomaMatthew L. Bootsma, Shuang G. Zhao, Rana R. McKay et al.|Journal of Clinical Oncology|2022Cited by 28
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical OutcomesMarina N. Sharifi, Joshua M. Lang, Jamie M. Sperger et al.|Cancer Discovery|2025Cited by 16
Adjuvant immunotherapy in patients with high‐risk muscle‐invasive urothelial carcinoma: The potential impact of informative censoringAlberto Martini, Matthew D. Galsky, Menggang Yu et al.|Cancer|2022Cited by 12